Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
about
Cytopathologic, histopathologic, and immunohistochemical features of intrahepatic clear cell bile duct adenoma: a case report and review of the literatureCM2 antigen, a potential novel molecule participating in glucuronide transport on rat hepatocyte canalicular membrane.Coexpression of CD14 and CD326 discriminate hepatic precursors in the human fetal liver.Cooperative effects of aminopeptidase N (CD13) expressed by nonmalignant and cancer cells within the tumor microenvironmentExpression, immunogenicity, histopathology, and potency of a mosquito-based malaria transmission-blocking recombinant vaccine.Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues.Prognostic significance of aberrantly silenced ANPEP expression in prostate cancer.Biliary tract cancer stem cells - translational options and challenges.Surveillance and diagnosis of hepatocellular carcinoma in patients with cirrhosis.Clinical significance of CD13 and epithelial mesenchymal transition (EMT) markers in hepatocellular carcinoma.Prognostic significance of aminopeptidase-N (CD13) in hepatoblastoma.
P2860
Q33736353-7F2D5FD7-DED1-457C-86A8-C78EA3431B01Q34426099-0712903B-EBD2-4DBF-A425-4820B47DD1C3Q35064611-59A8D29B-DCE1-4A1D-B8B0-DC780E24A44BQ35749834-5E98F53E-F749-4C6A-95DF-A07D37E47B56Q35867612-81881B03-4096-4BE4-9A69-D3725CDDE954Q38819807-07E09024-47C8-4EEB-95CA-E01C38D922AAQ39209834-267029B3-D667-437A-81D3-F27DB5221C7FQ39279276-1D4A9446-352A-42E5-B5B4-D8B9D8C02367Q41140599-EA48AEA4-C09B-463D-B760-C26A2DBDFD15Q47395337-7B92E7D0-A1FE-41FF-906E-43708B715B5AQ52966943-049FEEA2-224F-423E-A3D5-F09CD5F16398
P2860
Canalicular immunostaining of aminopeptidase N (CD13) as a diagnostic marker for hepatocellular carcinoma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Canalicular immunostaining of ...... for hepatocellular carcinoma.
@ast
Canalicular immunostaining of ...... for hepatocellular carcinoma.
@en
type
label
Canalicular immunostaining of ...... for hepatocellular carcinoma.
@ast
Canalicular immunostaining of ...... for hepatocellular carcinoma.
@en
prefLabel
Canalicular immunostaining of ...... for hepatocellular carcinoma.
@ast
Canalicular immunostaining of ...... for hepatocellular carcinoma.
@en
P2093
P2860
P356
P1476
Canalicular immunostaining of ...... for hepatocellular carcinoma.
@en
P2093
Carl-McGrath S
Roessner A
P2860
P304
P356
10.1136/JCP.2005.026328
P407
P577
2005-10-01T00:00:00Z